Engene Holdings Inc.

Biotechnology • Healthcare • Montreal, QC, United States • ENGNW (NCM)

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGene Holdings Inc. is based in Montreal, Canada.

514 332 4888 4868 Rue Levy, Montreal, QC H4R 2P1, Canada

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN) - Seeking Alpha

Seeking Alpha • Dec 26

enGene Holdings (ENGN) Price Target Increased by 10.59% to 24.20 - Nasdaq

Nasdaq • Nov 17

enGene Holdings (ENGN) Is Up 36.9% After Strong Phase 2 Bladder Cancer Gene Therapy Results - Yahoo Finance

Yahoo Finance • Nov 13

enGene Holdings Inc. (NASDAQ:ENGN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

MarketBeat • Dec 16

Here’s Why enGene Holdings Stock Is Soaring Today - TipRanks

TipRanks • Nov 11

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has enGene Holdings Inc. had layoffs?

No layoff events have been recorded for enGene Holdings Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does enGene Holdings Inc. have?

enGene Holdings Inc. has approximately 81 employees.

What industry is enGene Holdings Inc. in?

enGene Holdings Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is enGene Holdings Inc. a publicly traded company?

Yes, enGene Holdings Inc. is publicly traded under the ticker symbol ENGNW on the NCM.

Where is enGene Holdings Inc. headquartered?

enGene Holdings Inc. is headquartered in Montreal, QC, United States at 4868 Rue Levy, Montreal, QC H4R 2P1, Canada.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.